Cable Hill Partners’s Lisata Therapeutics LSTA Stock Holding History

Cable Hill Partners’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-33	Closed	-$2K	–	455
2019 Q1	$2K	Buy	+33	New	+$2.17K	﹤0.01%	757

Other funds holding LSTA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

WesBanco Bank Wheeling, West Virginia $3.61B AUM 24.09% 1-Year Est. Return

Cable Hill Partners's LSTA Position: Q2 2019 in Review

Cable Hill Partners sold out of Lisata Therapeutics (LSTA) in Q2 2019, closing a stake of 33 shares — an estimated $2K sold.

Cable Hill Partners first reported a position in LSTA in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 26 funds tracked by Wall St. Rank hold LSTA as of Q2 2019.

Cable Hill Partners reported no remaining Lisata Therapeutics position as of Q2 2019 after selling out during the quarter.
Cable Hill Partners sold 33 Lisata Therapeutics shares in Q2 2019, an estimated $2K.
Cable Hill Partners first reported a position in Lisata Therapeutics in Q1 2019 and held it in 1 quarter.
Cable Hill Partners's Lisata Therapeutics position peaked at $2K in Q1 2019.
26 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.